Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
Advertisement
Transition Therapeutics Inc. announced that Ms. Laura Agensky has been appointed Vice-President of Clinical Operations. Since joining Transition in 2001, Ms. Agensky has managed the execution of all the Company's clinical trials across a diverse set of disease indications including Alzheimer's disease and diabetes. Prior to Transition, she served in multiple clinical development roles at large pharmaceutical, biotechnology and consulting organizations. As Vice-President, Ms. Agensky will continue to lead Transition's clinical operations group.
Most read news
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Shaping up the Genome for Cell Division - Researchers have uncovered the inner workings of the molecular machinery that shapes chromosomes during cell division
Thyroid_cancer
Cross-industry alliance develops and pilots model for measuring the value contributions to the environment, society, and businesses - BASF is founding member of “value balancing alliance e.V.”
Georg_Friedrich_Nicolai
Merck Named a Global Top Employer
Category:GnRH_agonists
Pick's_disease
Reading the pancreas through the eye

Mysteries of enzyme mechanism revealed

Cell Cultivation without Contamination - Hot air sterilization and other means of contamination control in CO2 incubators
Figments_of_Reality
